Type | Description |
---|---|
Definition | solute carrier family 25 member 6 |
Date | Results | Publications |
---|---|---|
2016-11-05 11:36:00 | cancer cells require both hANT2 and hANT3, depending on their proliferation status: hANT2 when proliferation rates are high, and hANT3 when proliferation slows. | 26842067 |
2016-01-16 12:23:00 | Human ANT3 expression is directly downregulated by overexpression of hcmv-miR-UL36-5p. | 26212361 |
2013-07-02 10:26:00 | Compares and contrasts all the known human SLC25A* genes and includes functional information. | 23266187 |
2010-05-03 11:36:00 | The dynamics of the molecular interactions between the C-terminal region of PB1-F2 protein and VDAC1 and ANT3 were expounded by employing an in silico approach. | 19669810 |
2010-01-21 00:00:00 | These data suggest that the down-regulation of ANT3 levels upon stimulation with CPT may be involved in the molecular mechanism underlying acquired resistance to camptothecin. | 19111545 |
Type | IDs |
---|---|
Synonymous | AAC3, ANT, ANT 2, ANT 3, ANT3, ANT3Y |
Gene |
UniProtKB-ID:
ADT3_HUMAN,
Q6I9V5_HUMAN
UniprotKB:
P12236,
Q6I9V5
UniParc:
UPI00000015FE
EMBL:
BC007850,
BC007295,
BC014775,
CH471074,
AK312336,
BC008737,
J03592,
BC008935,
BC031912,
GQ891512,
CR457400,
AY007135
Ensembl:
ENSG00000169100
KO:
hsa:293
|
Nucleutide sequences |
EMBL-CDS:
AAH07850.1,
AAH14775.1,
AAH31912.1,
AAH07295.1,
AAH08737.1,
AAG01998.1,
AAH08935.1,
AAA36750.1,
ADO22374.1,
EAW98680.1,
BAG35257.1,
CAG33681.1
Gene_ORFName:
CDABP0051,
hCG_1746794
Ensembl_TRS:
ENST00000381401
|
Protein sequencees |
Ensembl_PRO:
ENSP00000370808
RefSeq:
NP_001627.2
|
Others |
UniRef100:
UniRef100_P12236
UniRef90:
UniRef90_P12236
UniRef50:
UniRef50_P12236
UniGene:
Hs.350927
CCDS:
CCDS14114.1
|
{{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
---|---|---|---|---|---|---|---|---|
Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
暂无数据
排名 | 科研单位 | 文献 |
---|---|---|
{{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
排名 | 研究人员 | 文献 |
---|---|---|
{{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员